Advancing Research and Treatment for Frontotemporal Lobar Degeneration (ARTFL)
An observational study for individuals diagnosed with an FTLD disorder as well as members of families with a history of FTLD disorders.
Sponsor: National Institutes of Health
Enrolling: Male and Female Patients
IRB Number: AAAP0951
U.S. Govt. ID: NCT02365922
Contact: Masood Manoochehri: 212-305-5710 / mm2626@cumc.columbia.edu
Additional Study Information: This is an observational study designed to collect information about Frontotemporal Lobar Degeneration (FTLD) disorders. FTLD is a term for a related group of neurodegenerative disorders that cause impairments in personality, cognitive ability, language, and motor function. This study aims to build a reliable clinical research network to support treatment and prevention clinical trials for FTLD. The study has multiple projects, and eligible participants may include both individuals diagnosed with an FTLD disorder as well as members of families with a history of FTLD disorders, such as Frontotemporal Dementia (FTD), Primary Progressive Aphasia (PPA), Progressive Supranuclear Palsy (PSP), Corticobasal Degeneration Syndrome (CBD), or Frontotemporal Dementia with Amyotrophic Lateral Sclerosis (FTD-ALS).
This study is closed
Investigator
Matthew Harms, MD
Do You Qualify?
Do you have an FTLD disorder or have a family member with and FTLD disorder? Yes No
Are you able to walk (or walk with assistance)? Yes No
Do you have a friend or family member who can accompany you to visits? Yes No
Do you speak English? Yes No
Submit
Cancel
You may be eligible for this study

Place Holder




For more information, please contact:
Masood Manoochehri
mm2626@cumc.columbia.edu
212-305-5710